Amgen Limited and Amgen Ireland Limited are committed to fully complying with the disclosure requirements of the ABPI Code of Practice for the Pharmaceutical Industry and the IPHA Code of Practice for the Pharmaceutical Industry respectively.
Amgen’s Joint Working Initiatives are projects implemented under an agreement with the NHS to address shared goals in relation to health systems and patient care.
This includes information on our work with patient advocacy groups including details of the level of funding provided.
We disclose payments we make to healthcare professionals, healthcare and other organisations and in research work such as clinical trials, non-clinical studies and non-interventional studies.
We disclose payments we make to members of the UK public, including patients.